nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ACE—forelimb zeugopod—head and neck cancer	0.0319	0.339	CbGeAlD
Perindopril—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00941	0.0104	CcSEcCtD
Perindopril—Blood urea increased—Hydroxyurea—head and neck cancer	0.00872	0.00963	CcSEcCtD
Perindopril—Lacrimation—Docetaxel—head and neck cancer	0.00816	0.00901	CcSEcCtD
Perindopril—Speech disorder—Fluorouracil—head and neck cancer	0.00773	0.00854	CcSEcCtD
Perindopril—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00751	0.00828	CcSEcCtD
Perindopril—Hepatic failure—Hydroxyurea—head and neck cancer	0.00746	0.00824	CcSEcCtD
Perindopril—Renal failure acute—Hydroxyurea—head and neck cancer	0.00727	0.00802	CcSEcCtD
Perindopril—Lacrimation increased—Fluorouracil—head and neck cancer	0.00722	0.00797	CcSEcCtD
Perindopril—Leukocytosis—Fluorouracil—head and neck cancer	0.00708	0.00781	CcSEcCtD
Perindopril—Face oedema—Hydroxyurea—head and neck cancer	0.00648	0.00715	CcSEcCtD
Perindopril—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00628	0.00694	CcSEcCtD
Perindopril—Angina pectoris—Vinblastine—head and neck cancer	0.00619	0.00683	CcSEcCtD
Perindopril—Breast disorder—Hydroxyurea—head and neck cancer	0.00606	0.00669	CcSEcCtD
Perindopril—Pancytopenia—Vinblastine—head and neck cancer	0.00604	0.00666	CcSEcCtD
Perindopril—Rhinorrhoea—Docetaxel—head and neck cancer	0.00593	0.00654	CcSEcCtD
Perindopril—ACE—mouth—head and neck cancer	0.00577	0.0613	CbGeAlD
Perindopril—Pancreatitis—Hydroxyurea—head and neck cancer	0.00568	0.00627	CcSEcCtD
Perindopril—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00559	0.00617	CcSEcCtD
Perindopril—Myocardial infarction—Vinblastine—head and neck cancer	0.00556	0.00613	CcSEcCtD
Perindopril—Pancytopenia—Hydroxyurea—head and neck cancer	0.00551	0.00608	CcSEcCtD
Perindopril—Neutropenia—Hydroxyurea—head and neck cancer	0.00542	0.00598	CcSEcCtD
Perindopril—Bone disorder—Docetaxel—head and neck cancer	0.00531	0.00587	CcSEcCtD
Perindopril—Agranulocytosis—Vinblastine—head and neck cancer	0.00529	0.00584	CcSEcCtD
Perindopril—Oliguria—Docetaxel—head and neck cancer	0.00521	0.00575	CcSEcCtD
Perindopril—Lacrimation increased—Docetaxel—head and neck cancer	0.00521	0.00575	CcSEcCtD
Perindopril—Drug interaction—Docetaxel—head and neck cancer	0.00517	0.00571	CcSEcCtD
Perindopril—Drowsiness—Hydroxyurea—head and neck cancer	0.00517	0.00571	CcSEcCtD
Perindopril—Amnesia—Fluorouracil—head and neck cancer	0.00514	0.00567	CcSEcCtD
Perindopril—Haemoglobin—Vinblastine—head and neck cancer	0.00511	0.00564	CcSEcCtD
Perindopril—Haemorrhage—Vinblastine—head and neck cancer	0.00509	0.00562	CcSEcCtD
Perindopril—Pharyngitis—Vinblastine—head and neck cancer	0.00505	0.00557	CcSEcCtD
Perindopril—Stomatitis—Hydroxyurea—head and neck cancer	0.00504	0.00556	CcSEcCtD
Perindopril—SLC15A2—mouth—head and neck cancer	0.00503	0.0535	CbGeAlD
Perindopril—Bone pain—Docetaxel—head and neck cancer	0.00501	0.00553	CcSEcCtD
Perindopril—ACE—neck—head and neck cancer	0.00493	0.0524	CbGeAlD
Perindopril—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00489	0.0054	CcSEcCtD
Perindopril—Blood pressure increased—Docetaxel—head and neck cancer	0.0048	0.0053	CcSEcCtD
Perindopril—SLC15A1—epithelium—head and neck cancer	0.00468	0.0498	CbGeAlD
Perindopril—Haemoglobin—Hydroxyurea—head and neck cancer	0.00466	0.00515	CcSEcCtD
Perindopril—Haemorrhage—Hydroxyurea—head and neck cancer	0.00464	0.00512	CcSEcCtD
Perindopril—Hallucination—Hydroxyurea—head and neck cancer	0.00462	0.0051	CcSEcCtD
Perindopril—Cardiac arrest—Fluorouracil—head and neck cancer	0.00459	0.00507	CcSEcCtD
Perindopril—Fluid retention—Docetaxel—head and neck cancer	0.00456	0.00503	CcSEcCtD
Perindopril—Alopecia—Vinblastine—head and neck cancer	0.0045	0.00496	CcSEcCtD
Perindopril—Dry skin—Fluorouracil—head and neck cancer	0.00443	0.00488	CcSEcCtD
Perindopril—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00432	0.00477	CcSEcCtD
Perindopril—Muscular weakness—Fluorouracil—head and neck cancer	0.00426	0.0047	CcSEcCtD
Perindopril—Angiopathy—Hydroxyurea—head and neck cancer	0.00421	0.00465	CcSEcCtD
Perindopril—Chills—Hydroxyurea—head and neck cancer	0.00416	0.0046	CcSEcCtD
Perindopril—Eosinophilia—Fluorouracil—head and neck cancer	0.00413	0.00456	CcSEcCtD
Perindopril—Ill-defined disorder—Vinblastine—head and neck cancer	0.00411	0.00454	CcSEcCtD
Perindopril—Alopecia—Hydroxyurea—head and neck cancer	0.0041	0.00453	CcSEcCtD
Perindopril—Anaemia—Vinblastine—head and neck cancer	0.00409	0.00452	CcSEcCtD
Perindopril—Angina pectoris—Fluorouracil—head and neck cancer	0.00406	0.00449	CcSEcCtD
Perindopril—Erythema—Hydroxyurea—head and neck cancer	0.00404	0.00446	CcSEcCtD
Perindopril—Malaise—Vinblastine—head and neck cancer	0.00399	0.00441	CcSEcCtD
Perindopril—Vertigo—Vinblastine—head and neck cancer	0.00398	0.00439	CcSEcCtD
Perindopril—Leukopenia—Vinblastine—head and neck cancer	0.00396	0.00438	CcSEcCtD
Perindopril—Pancytopenia—Fluorouracil—head and neck cancer	0.00396	0.00437	CcSEcCtD
Perindopril—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00388	0.00428	CcSEcCtD
Perindopril—Hepatic failure—Docetaxel—head and neck cancer	0.00388	0.00428	CcSEcCtD
Perindopril—Hypertension—Vinblastine—head and neck cancer	0.00382	0.00422	CcSEcCtD
Perindopril—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00381	0.0042	CcSEcCtD
Perindopril—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00375	0.00414	CcSEcCtD
Perindopril—Pneumonia—Fluorouracil—head and neck cancer	0.00374	0.00413	CcSEcCtD
Perindopril—Anaemia—Hydroxyurea—head and neck cancer	0.00373	0.00412	CcSEcCtD
Perindopril—Discomfort—Vinblastine—head and neck cancer	0.00373	0.00411	CcSEcCtD
Perindopril—Hot flush—Docetaxel—head and neck cancer	0.00373	0.00411	CcSEcCtD
Perindopril—Menopausal symptoms—Docetaxel—head and neck cancer	0.00369	0.00408	CcSEcCtD
Perindopril—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00367	0.00405	CcSEcCtD
Perindopril—Renal impairment—Docetaxel—head and neck cancer	0.00366	0.00404	CcSEcCtD
Perindopril—Myocardial infarction—Fluorouracil—head and neck cancer	0.00365	0.00403	CcSEcCtD
Perindopril—Malaise—Hydroxyurea—head and neck cancer	0.00364	0.00402	CcSEcCtD
Perindopril—Stomatitis—Fluorouracil—head and neck cancer	0.00363	0.004	CcSEcCtD
Perindopril—Urinary tract infection—Fluorouracil—head and neck cancer	0.00362	0.00399	CcSEcCtD
Perindopril—Conjunctivitis—Fluorouracil—head and neck cancer	0.00362	0.00399	CcSEcCtD
Perindopril—Leukopenia—Hydroxyurea—head and neck cancer	0.00362	0.00399	CcSEcCtD
Perindopril—Thrombocytopenia—Vinblastine—head and neck cancer	0.00354	0.00391	CcSEcCtD
Perindopril—ACE—connective tissue—head and neck cancer	0.00353	0.0376	CbGeAlD
Perindopril—Epistaxis—Fluorouracil—head and neck cancer	0.00351	0.00387	CcSEcCtD
Perindopril—SLC15A2—parotid gland—head and neck cancer	0.0035	0.0372	CbGeAlD
Perindopril—Hyponatraemia—Docetaxel—head and neck cancer	0.0035	0.00386	CcSEcCtD
Perindopril—Sinusitis—Fluorouracil—head and neck cancer	0.00349	0.00385	CcSEcCtD
Perindopril—Pain in extremity—Docetaxel—head and neck cancer	0.00348	0.00385	CcSEcCtD
Perindopril—Agranulocytosis—Fluorouracil—head and neck cancer	0.00347	0.00383	CcSEcCtD
Perindopril—Anorexia—Vinblastine—head and neck cancer	0.00345	0.0038	CcSEcCtD
Perindopril—Migraine—Docetaxel—head and neck cancer	0.00343	0.00379	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00342	0.00377	CcSEcCtD
Perindopril—Discomfort—Hydroxyurea—head and neck cancer	0.0034	0.00375	CcSEcCtD
Perindopril—Haemoglobin—Fluorouracil—head and neck cancer	0.00336	0.00371	CcSEcCtD
Perindopril—ACE—epithelium—head and neck cancer	0.00336	0.0357	CbGeAlD
Perindopril—SLC15A2—saliva-secreting gland—head and neck cancer	0.00335	0.0357	CbGeAlD
Perindopril—Rhinitis—Fluorouracil—head and neck cancer	0.00335	0.0037	CcSEcCtD
Perindopril—Haemorrhage—Fluorouracil—head and neck cancer	0.00334	0.00369	CcSEcCtD
Perindopril—Pharyngitis—Fluorouracil—head and neck cancer	0.00331	0.00366	CcSEcCtD
Perindopril—Oedema—Hydroxyurea—head and neck cancer	0.0033	0.00364	CcSEcCtD
Perindopril—Paraesthesia—Vinblastine—head and neck cancer	0.00325	0.00358	CcSEcCtD
Perindopril—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00323	0.00357	CcSEcCtD
Perindopril—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00323	0.00356	CcSEcCtD
Perindopril—Skin disorder—Hydroxyurea—head and neck cancer	0.0032	0.00353	CcSEcCtD
Perindopril—Dry skin—Docetaxel—head and neck cancer	0.00319	0.00353	CcSEcCtD
Perindopril—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00318	0.00351	CcSEcCtD
Perindopril—Abdominal pain upper—Docetaxel—head and neck cancer	0.00318	0.00351	CcSEcCtD
Perindopril—Breast disorder—Docetaxel—head and neck cancer	0.00315	0.00348	CcSEcCtD
Perindopril—Anorexia—Hydroxyurea—head and neck cancer	0.00314	0.00347	CcSEcCtD
Perindopril—Decreased appetite—Vinblastine—head and neck cancer	0.00314	0.00347	CcSEcCtD
Perindopril—Cramp muscle—Docetaxel—head and neck cancer	0.00314	0.00346	CcSEcCtD
Perindopril—Nasopharyngitis—Docetaxel—head and neck cancer	0.00312	0.00344	CcSEcCtD
Perindopril—Constipation—Vinblastine—head and neck cancer	0.00309	0.00341	CcSEcCtD
Perindopril—Pain—Vinblastine—head and neck cancer	0.00309	0.00341	CcSEcCtD
Perindopril—Arrhythmia—Fluorouracil—head and neck cancer	0.00298	0.00329	CcSEcCtD
Perindopril—Feeling abnormal—Vinblastine—head and neck cancer	0.00298	0.00329	CcSEcCtD
Perindopril—Bronchospasm—Docetaxel—head and neck cancer	0.00296	0.00327	CcSEcCtD
Perindopril—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00296	0.00326	CcSEcCtD
Perindopril—Alopecia—Fluorouracil—head and neck cancer	0.00295	0.00326	CcSEcCtD
Perindopril—Dyspnoea—Hydroxyurea—head and neck cancer	0.00294	0.00324	CcSEcCtD
Perindopril—Angina pectoris—Docetaxel—head and neck cancer	0.00293	0.00324	CcSEcCtD
Perindopril—Somnolence—Hydroxyurea—head and neck cancer	0.00293	0.00323	CcSEcCtD
Perindopril—Erythema—Fluorouracil—head and neck cancer	0.00291	0.00321	CcSEcCtD
Perindopril—Dyspepsia—Hydroxyurea—head and neck cancer	0.0029	0.0032	CcSEcCtD
Perindopril—Decreased appetite—Hydroxyurea—head and neck cancer	0.00287	0.00316	CcSEcCtD
Perindopril—Pancytopenia—Docetaxel—head and neck cancer	0.00286	0.00316	CcSEcCtD
Perindopril—Abdominal pain—Vinblastine—head and neck cancer	0.00286	0.00315	CcSEcCtD
Perindopril—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00285	0.00314	CcSEcCtD
Perindopril—Fatigue—Hydroxyurea—head and neck cancer	0.00284	0.00314	CcSEcCtD
Perindopril—Constipation—Hydroxyurea—head and neck cancer	0.00282	0.00311	CcSEcCtD
Perindopril—Pain—Hydroxyurea—head and neck cancer	0.00282	0.00311	CcSEcCtD
Perindopril—Neutropenia—Docetaxel—head and neck cancer	0.00282	0.00311	CcSEcCtD
Perindopril—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00272	0.003	CcSEcCtD
Perindopril—Pneumonia—Docetaxel—head and neck cancer	0.0027	0.00298	CcSEcCtD
Perindopril—Anaemia—Fluorouracil—head and neck cancer	0.00269	0.00297	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00266	0.00294	CcSEcCtD
Perindopril—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00265	0.00292	CcSEcCtD
Perindopril—Renal failure—Docetaxel—head and neck cancer	0.00264	0.00291	CcSEcCtD
Perindopril—Myocardial infarction—Docetaxel—head and neck cancer	0.00263	0.00291	CcSEcCtD
Perindopril—Stomatitis—Docetaxel—head and neck cancer	0.00262	0.00289	CcSEcCtD
Perindopril—Jaundice—Docetaxel—head and neck cancer	0.00262	0.00289	CcSEcCtD
Perindopril—Conjunctivitis—Docetaxel—head and neck cancer	0.00261	0.00288	CcSEcCtD
Perindopril—Body temperature increased—Hydroxyurea—head and neck cancer	0.00261	0.00288	CcSEcCtD
Perindopril—Leukopenia—Fluorouracil—head and neck cancer	0.0026	0.00287	CcSEcCtD
Perindopril—Asthenia—Vinblastine—head and neck cancer	0.00259	0.00286	CcSEcCtD
Perindopril—SLC15A2—trachea—head and neck cancer	0.00259	0.0275	CbGeAlD
Perindopril—ACE—lymphoid tissue—head and neck cancer	0.00258	0.0275	CbGeAlD
Perindopril—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00254	0.0028	CcSEcCtD
Perindopril—Epistaxis—Docetaxel—head and neck cancer	0.00253	0.0028	CcSEcCtD
Perindopril—Agranulocytosis—Docetaxel—head and neck cancer	0.00251	0.00277	CcSEcCtD
Perindopril—Myalgia—Fluorouracil—head and neck cancer	0.00248	0.00273	CcSEcCtD
Perindopril—Chest pain—Fluorouracil—head and neck cancer	0.00248	0.00273	CcSEcCtD
Perindopril—Diarrhoea—Vinblastine—head and neck cancer	0.00247	0.00273	CcSEcCtD
Perindopril—Discomfort—Fluorouracil—head and neck cancer	0.00245	0.0027	CcSEcCtD
Perindopril—Haemoglobin—Docetaxel—head and neck cancer	0.00242	0.00267	CcSEcCtD
Perindopril—Rhinitis—Docetaxel—head and neck cancer	0.00242	0.00267	CcSEcCtD
Perindopril—Haemorrhage—Docetaxel—head and neck cancer	0.00241	0.00266	CcSEcCtD
Perindopril—Hepatitis—Docetaxel—head and neck cancer	0.00241	0.00266	CcSEcCtD
Perindopril—Confusional state—Fluorouracil—head and neck cancer	0.00239	0.00264	CcSEcCtD
Perindopril—Pharyngitis—Docetaxel—head and neck cancer	0.00239	0.00264	CcSEcCtD
Perindopril—Dizziness—Vinblastine—head and neck cancer	0.00239	0.00264	CcSEcCtD
Perindopril—Urinary tract disorder—Docetaxel—head and neck cancer	0.00238	0.00263	CcSEcCtD
Perindopril—Oedema peripheral—Docetaxel—head and neck cancer	0.00237	0.00262	CcSEcCtD
Perindopril—Oedema—Fluorouracil—head and neck cancer	0.00237	0.00262	CcSEcCtD
Perindopril—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00237	0.00262	CcSEcCtD
Perindopril—Asthenia—Hydroxyurea—head and neck cancer	0.00237	0.00261	CcSEcCtD
Perindopril—Urethral disorder—Docetaxel—head and neck cancer	0.00236	0.00261	CcSEcCtD
Perindopril—ACE—thyroid gland—head and neck cancer	0.00235	0.025	CbGeAlD
Perindopril—Nervous system disorder—Fluorouracil—head and neck cancer	0.00233	0.00257	CcSEcCtD
Perindopril—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00232	0.00256	CcSEcCtD
Perindopril—Visual impairment—Docetaxel—head and neck cancer	0.00232	0.00256	CcSEcCtD
Perindopril—Tachycardia—Fluorouracil—head and neck cancer	0.00232	0.00256	CcSEcCtD
Perindopril—Vomiting—Vinblastine—head and neck cancer	0.0023	0.00254	CcSEcCtD
Perindopril—Erythema multiforme—Docetaxel—head and neck cancer	0.00228	0.00252	CcSEcCtD
Perindopril—Headache—Vinblastine—head and neck cancer	0.00226	0.0025	CcSEcCtD
Perindopril—Anorexia—Fluorouracil—head and neck cancer	0.00226	0.0025	CcSEcCtD
Perindopril—Diarrhoea—Hydroxyurea—head and neck cancer	0.00226	0.00249	CcSEcCtD
Perindopril—Eye disorder—Docetaxel—head and neck cancer	0.00225	0.00249	CcSEcCtD
Perindopril—Flushing—Docetaxel—head and neck cancer	0.00224	0.00247	CcSEcCtD
Perindopril—Cardiac disorder—Docetaxel—head and neck cancer	0.00224	0.00247	CcSEcCtD
Perindopril—Hypotension—Fluorouracil—head and neck cancer	0.00222	0.00245	CcSEcCtD
Perindopril—BCHE—trachea—head and neck cancer	0.00219	0.0233	CbGeAlD
Perindopril—Angiopathy—Docetaxel—head and neck cancer	0.00219	0.00241	CcSEcCtD
Perindopril—Dizziness—Hydroxyurea—head and neck cancer	0.00218	0.00241	CcSEcCtD
Perindopril—Mediastinal disorder—Docetaxel—head and neck cancer	0.00217	0.0024	CcSEcCtD
Perindopril—Chills—Docetaxel—head and neck cancer	0.00216	0.00239	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00216	0.00239	CcSEcCtD
Perindopril—Arrhythmia—Docetaxel—head and neck cancer	0.00215	0.00238	CcSEcCtD
Perindopril—Nausea—Vinblastine—head and neck cancer	0.00215	0.00237	CcSEcCtD
Perindopril—Insomnia—Fluorouracil—head and neck cancer	0.00215	0.00237	CcSEcCtD
Perindopril—Paraesthesia—Fluorouracil—head and neck cancer	0.00213	0.00235	CcSEcCtD
Perindopril—Alopecia—Docetaxel—head and neck cancer	0.00213	0.00235	CcSEcCtD
Perindopril—Dyspnoea—Fluorouracil—head and neck cancer	0.00212	0.00234	CcSEcCtD
Perindopril—Mental disorder—Docetaxel—head and neck cancer	0.00211	0.00233	CcSEcCtD
Perindopril—Somnolence—Fluorouracil—head and neck cancer	0.00211	0.00233	CcSEcCtD
Perindopril—Malnutrition—Docetaxel—head and neck cancer	0.0021	0.00232	CcSEcCtD
Perindopril—Erythema—Docetaxel—head and neck cancer	0.0021	0.00232	CcSEcCtD
Perindopril—Vomiting—Hydroxyurea—head and neck cancer	0.0021	0.00231	CcSEcCtD
Perindopril—Dyspepsia—Fluorouracil—head and neck cancer	0.00209	0.00231	CcSEcCtD
Perindopril—ACE—head—head and neck cancer	0.00208	0.0221	CbGeAlD
Perindopril—Rash—Hydroxyurea—head and neck cancer	0.00208	0.00229	CcSEcCtD
Perindopril—Dermatitis—Hydroxyurea—head and neck cancer	0.00208	0.00229	CcSEcCtD
Perindopril—Headache—Hydroxyurea—head and neck cancer	0.00207	0.00228	CcSEcCtD
Perindopril—Decreased appetite—Fluorouracil—head and neck cancer	0.00206	0.00228	CcSEcCtD
Perindopril—Dysgeusia—Docetaxel—head and neck cancer	0.00206	0.00227	CcSEcCtD
Perindopril—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00205	0.00226	CcSEcCtD
Perindopril—SLC15A2—thyroid gland—head and neck cancer	0.00205	0.0218	CbGeAlD
Perindopril—Back pain—Docetaxel—head and neck cancer	0.00203	0.00224	CcSEcCtD
Perindopril—Pain—Fluorouracil—head and neck cancer	0.00203	0.00224	CcSEcCtD
Perindopril—Muscle spasms—Docetaxel—head and neck cancer	0.00202	0.00223	CcSEcCtD
Perindopril—Nausea—Hydroxyurea—head and neck cancer	0.00196	0.00216	CcSEcCtD
Perindopril—Feeling abnormal—Fluorouracil—head and neck cancer	0.00196	0.00216	CcSEcCtD
Perindopril—Anaemia—Docetaxel—head and neck cancer	0.00194	0.00214	CcSEcCtD
Perindopril—Urticaria—Fluorouracil—head and neck cancer	0.00189	0.00208	CcSEcCtD
Perindopril—Syncope—Docetaxel—head and neck cancer	0.00188	0.00208	CcSEcCtD
Perindopril—Leukopenia—Docetaxel—head and neck cancer	0.00188	0.00207	CcSEcCtD
Perindopril—Body temperature increased—Fluorouracil—head and neck cancer	0.00188	0.00207	CcSEcCtD
Perindopril—Palpitations—Docetaxel—head and neck cancer	0.00185	0.00205	CcSEcCtD
Perindopril—Loss of consciousness—Docetaxel—head and neck cancer	0.00184	0.00204	CcSEcCtD
Perindopril—Cough—Docetaxel—head and neck cancer	0.00183	0.00202	CcSEcCtD
Perindopril—SLC15A2—head—head and neck cancer	0.00182	0.0193	CbGeAlD
Perindopril—Hypertension—Docetaxel—head and neck cancer	0.00181	0.002	CcSEcCtD
Perindopril—Chest pain—Docetaxel—head and neck cancer	0.00179	0.00197	CcSEcCtD
Perindopril—Myalgia—Docetaxel—head and neck cancer	0.00179	0.00197	CcSEcCtD
Perindopril—Arthralgia—Docetaxel—head and neck cancer	0.00179	0.00197	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00177	0.00196	CcSEcCtD
Perindopril—Dry mouth—Docetaxel—head and neck cancer	0.00175	0.00193	CcSEcCtD
Perindopril—BCHE—thyroid gland—head and neck cancer	0.00173	0.0184	CbGeAlD
Perindopril—Confusional state—Docetaxel—head and neck cancer	0.00173	0.00191	CcSEcCtD
Perindopril—Oedema—Docetaxel—head and neck cancer	0.00171	0.00189	CcSEcCtD
Perindopril—Anaphylactic shock—Docetaxel—head and neck cancer	0.00171	0.00189	CcSEcCtD
Perindopril—Shock—Docetaxel—head and neck cancer	0.00169	0.00186	CcSEcCtD
Perindopril—Nervous system disorder—Docetaxel—head and neck cancer	0.00168	0.00185	CcSEcCtD
Perindopril—Pruritus—Fluorouracil—head and neck cancer	0.00168	0.00185	CcSEcCtD
Perindopril—Thrombocytopenia—Docetaxel—head and neck cancer	0.00168	0.00185	CcSEcCtD
Perindopril—Tachycardia—Docetaxel—head and neck cancer	0.00167	0.00185	CcSEcCtD
Perindopril—Skin disorder—Docetaxel—head and neck cancer	0.00166	0.00184	CcSEcCtD
Perindopril—Anorexia—Docetaxel—head and neck cancer	0.00163	0.0018	CcSEcCtD
Perindopril—Diarrhoea—Fluorouracil—head and neck cancer	0.00162	0.00179	CcSEcCtD
Perindopril—Hypotension—Docetaxel—head and neck cancer	0.0016	0.00177	CcSEcCtD
Perindopril—Dizziness—Fluorouracil—head and neck cancer	0.00157	0.00173	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00156	0.00172	CcSEcCtD
Perindopril—Insomnia—Docetaxel—head and neck cancer	0.00155	0.00171	CcSEcCtD
Perindopril—BCHE—head—head and neck cancer	0.00154	0.0164	CbGeAlD
Perindopril—Paraesthesia—Docetaxel—head and neck cancer	0.00154	0.0017	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—head and neck cancer	0.00153	0.00169	CcSEcCtD
Perindopril—Somnolence—Docetaxel—head and neck cancer	0.00152	0.00168	CcSEcCtD
Perindopril—Vomiting—Fluorouracil—head and neck cancer	0.00151	0.00167	CcSEcCtD
Perindopril—Dyspepsia—Docetaxel—head and neck cancer	0.00151	0.00166	CcSEcCtD
Perindopril—Rash—Fluorouracil—head and neck cancer	0.0015	0.00165	CcSEcCtD
Perindopril—Dermatitis—Fluorouracil—head and neck cancer	0.00149	0.00165	CcSEcCtD
Perindopril—Decreased appetite—Docetaxel—head and neck cancer	0.00149	0.00164	CcSEcCtD
Perindopril—Headache—Fluorouracil—head and neck cancer	0.00149	0.00164	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00148	0.00163	CcSEcCtD
Perindopril—Fatigue—Docetaxel—head and neck cancer	0.00148	0.00163	CcSEcCtD
Perindopril—Pain—Docetaxel—head and neck cancer	0.00146	0.00162	CcSEcCtD
Perindopril—Constipation—Docetaxel—head and neck cancer	0.00146	0.00162	CcSEcCtD
Perindopril—ACE—lymph node—head and neck cancer	0.00146	0.0155	CbGeAlD
Perindopril—Feeling abnormal—Docetaxel—head and neck cancer	0.00141	0.00156	CcSEcCtD
Perindopril—Nausea—Fluorouracil—head and neck cancer	0.00141	0.00156	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—head and neck cancer	0.0014	0.00155	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—head and neck cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—head and neck cancer	0.00135	0.00149	CcSEcCtD
Perindopril—SLC15A2—lymph node—head and neck cancer	0.00127	0.0135	CbGeAlD
Perindopril—Asthenia—Docetaxel—head and neck cancer	0.00123	0.00136	CcSEcCtD
Perindopril—Pruritus—Docetaxel—head and neck cancer	0.00121	0.00134	CcSEcCtD
Perindopril—ABCB1—epithelium—head and neck cancer	0.00118	0.0126	CbGeAlD
Perindopril—Diarrhoea—Docetaxel—head and neck cancer	0.00117	0.00129	CcSEcCtD
Perindopril—Dizziness—Docetaxel—head and neck cancer	0.00113	0.00125	CcSEcCtD
Perindopril—Vomiting—Docetaxel—head and neck cancer	0.00109	0.0012	CcSEcCtD
Perindopril—Rash—Docetaxel—head and neck cancer	0.00108	0.00119	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—head and neck cancer	0.00108	0.00119	CcSEcCtD
Perindopril—BCHE—lymph node—head and neck cancer	0.00108	0.0115	CbGeAlD
Perindopril—Headache—Docetaxel—head and neck cancer	0.00107	0.00118	CcSEcCtD
Perindopril—ABCB1—trachea—head and neck cancer	0.00104	0.0111	CbGeAlD
Perindopril—Nausea—Docetaxel—head and neck cancer	0.00102	0.00112	CcSEcCtD
Perindopril—ABCB1—lymphoid tissue—head and neck cancer	0.00091	0.00968	CbGeAlD
Perindopril—ABCB1—thyroid gland—head and neck cancer	0.000826	0.00879	CbGeAlD
Perindopril—ABCB1—head—head and neck cancer	0.000733	0.0078	CbGeAlD
Perindopril—ABCB1—lymph node—head and neck cancer	0.000513	0.00546	CbGeAlD
